Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins (Q33391706)

26 July 2017

Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins (English)

1 reference

26 July 2017

Lijuan Zhang

1

1 reference

26 July 2017

1 January 2010

1 reference

Progress in Molecular Biology and Translational Science

26 July 2017

1 reference

26 July 2017

93

1 reference

26 July 2017

1-17

1 reference

Order out of chaos: assembly of ligand binding sites in heparan sulfate

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Biosynthesis of chondroitin/dermatan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

The elusive functions of proteoglycans: in vivo veritas

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Cell-surface heparan sulfate and heparan-sulfate/chondroitin-sulfate hybrid proteoglycans of mouse mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Proteoglycans in the nervous system--the quest for functional roles in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Matrix Glycosaminoglycans in the Growth Phase of Fibroblasts: More of the Story in Wound Healing

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Evidence for independent metabolism and cell surface localization of cell surface localization of cellular proteoglycans and glycosaminoglycan free chains

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Accumulation of a pentasaccharide terminating in alpha-N-acetylglucosamine in an animal cell mutant defective in heparan sulfate biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Influence of core protein sequence on glycosaminoglycan assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Mechanisms underlying preferential assembly of heparan sulfate on glypican-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Different usage of the glycosaminoglycan attachment sites of biglycan

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Novel sulfated oligosaccharides containing 3-O-sulfated glucuronic acid from king crab cartilage chondroitin sulfate K. Unexpected degradation by chondroitinase ABC.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Novel tetrasaccharides isolated from squid cartilage chondroitin sulfate E contain unusual sulfated disaccharide units GlcA(3-O-sulfate)beta1-3GalNAc(6-O-sulfate) or GlcA(3-O-sulfate)beta1-3GalNAc

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Molecular diversity of heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Specificities of heparan sulphate proteoglycans in developmental processes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Analysis of plasma proteins that bind to glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Cell surface-associated chondroitin sulfate proteoglycans bind contact phase factor H-kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding and activatory oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Structural determinants of heparan sulphate modulation of GDNF signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Antithrombotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Hyperglycaemia and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Anticoagulant use in patients with chronic renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Pulmonary and thrombotic manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

The approach to heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Oversulfated chondroitin sulfate is not the sole contaminant in heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Contaminated heparin associated with adverse clinical events and activation of the contact system

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

1 reference

7 January 2021

Oversulfated heparin by-products induce thrombin generation in human plasmas through contact system activation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Evidence for non-traditional activation of complement factor C3 during murine liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Generation of C5a in the absence of C3: a new complement activation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Identification of the heparan sulfate binding sites in the cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Prion protein conversion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Molecular characterization and genomic mapping of human IPM 200, a second member of a novel family of proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

SPACRCAN, a novel human interphotoreceptor matrix hyaluronan-binding proteoglycan synthesized by photoreceptors and pinealocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Modification of the laminin alpha 4 chain by chondroitin sulfate attachment to its N-terminal domain

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

cDNA cloning of the basement membrane chondroitin sulfate proteoglycan core protein, bamacan: a five domain structure including coiled-coil motifs

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

Identification and characterization of three Drosophila melanogaster glucuronyltransferases responsible for the synthesis of the conserved glycosaminoglycan-protein linkage region of proteoglycans. Two novel homologs exhibit broad specificity toward

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993001-9

7 January 2021

10.1016/S1877-1173(10)93001-9

Identifiers

DOI

1 reference

release_64s2tk5b5fepvpykcu27zyrkyi

26 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/64s2tk5b5fepvpykcu27zyrkyi

24 November 2022

mapped directly with Wikidata item

PubMed ID

20807638

1 reference

PubMed ID

20807638